Subacute occlusion, bleeding complications, hospital stay and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regimen

Journal of the American College of Cardiology

Volumn 27, Issue 1, 1996, Pages 22-29

  Fernández Avilés, Francisco ^a   Alonso, Joaquín Jesus ^a   Durán, Juan Manuel ^a   Gimeno, Federico ^a   Muñoz, Juan Carlos ^a   De La Fuente, Luis ^a   Román, José Alberto San ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DEXTRAN 40; DIPYRIDAMOLE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTHROMBIN TIME; STENT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0343027285     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00440-8     Document Type: Article

References (51)

1. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992;85:916-27.
2. George BS, Voorhees WD, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;22:135-43.
3. Sutton JM, Ellis SG, Roubin GS, et al. Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. Circulation 1994;89:1226-137.
4. Goy JL, Sigwart U, Vogt P, Stauffer JC, Kappenberger L. Long-term clinical and angiographic follow-up of patients treated with the self-expanding coronary stent for acute occlusion during balloon angioplasty of the right coronary artery. J Am Coll Cardiol 1992;19:1593-6.
5. Vrolix M, Piessens J, for the European Wiktor stent study group. Usefulness of the Wiktor stent for treatment of threatened or acute closure complicating coronary angioplasty. Am J Cardiol 1994;73:737-41.
6. Herrmann HC, Buchbinder M, Cleman MW, et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation 1992;86:812-9.
7. Maiello L, Colombo A, Gianrossi R, McCanny R, Finci L. Coronary stenting for treatment of acute or threatened closure following dissection after coronary balloon angioplasty. Am Heart J 1993;125:1570-5.
8. Kiemeneij F, Iaarman GJ, Wieken R, Suwarganda J. Emergency coronary stenting with the Palmaz-Schatz stent for failed transluminal coronary angioplasty: results of a learning phase. Am Heart J 1993;126:23-31.
9. Haude M, Erbel R, Straub U, Dietz U, Schatz R, Meyer J. Results of intracoronary stents for management of coronary dissection after balloon angioplasty. Am J Cardiol 1991;67:691-6.
10. Alonso J, Durán JM, Gimeno F, Fernández-Aviles F. Tratamiento de la oclusión coronaria aguda y de la "amenaza" de oclusión postangioplastia coronaria mediante implante de prótesis intracoronarias o "stent." Rev Esp Cardiol 1993;46:Suppl 3:97-109.
11. Ellis SG. The Palmaz-Schatz stent: clinical applications. In: Topol EJ, ed. Textbook of Interventional Cardiology. Philadelphia: Saunders, 1994:702-11.
12. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991;83:148-61.
13. Schatz RA, Goldberg S, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol 1991;17:155B-9B.
14. Carrozza JP, Kuntz RE, Levine MS, et al. Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience. J Am Coll Cardiol 1992;20:328-37.
15. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artey disease. N Engl J Med 1994;331:496-501.
16. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
17. Piana RN, Moscucci M, Cohen DJ, et al. Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. J Am Coll Cardiol 1994;23:1296-304.
18. Topol EJ. Caveats about elective coronary stenting. N Engl J Med 1994;331: 539-41.
19. Natch FC, Muller DWM, Ellis SG, et al. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Am Coll Cardiol 1993;21:622-7.
20. Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after coronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126:15-22.
21. Bermejo J, García-Robles JA, García EJ, Beloscar A, Delcan JL. Subacute occlusion after coronary stenting: predictors, management and mid-term outcome. Circulation 1994;90:I-650.
22. Liu MW, Agrawal SK, Cannon AD, et al. Is coronary stenting for acute or threatened closure a temporary bail-out device or definitive therapy? [abstract]. J Am Coll Cardiol 1993;21:177A.
23. Wong SC, Chuang YC, Schatz RA, et al. Predictors for adverse clinical events are different in stents and PTCA: results from the STent REStenosis Study [abstract]. J Am Coll Cardiol 1995;25:123A.
24. Rocha-Singh KS, Fischman DL, Savage MP, Goldberg S, Teirstein PS, Schatz PA. Influence of angiographic lesion characteristics on early complication rates after Palmaz-Schatz stenting [abstract]. J Am Coll Cardiol 1993;21:292A.
25. Serruys PW, Strauss BH, Beatt KS, et al. Angiographic follow-up after placement of a self-expanding coronary artery stent. N Engl J Med 1991; 324:13-7.
26. Palmaz JC, García OJ, Kopp DT, et al. Balloon expandable intraarterial stents: effects of antithrombotic medication on thrombus formation. In: Seither C, Seyferth W, editors. Pros and Cost in PTA and Auxiliary Methods. Berlin: Springer-Verlag, 1989:170-8.
27. Cohen DJ, Breall JA, Ho KKL, et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. Circulation 1994;89: 1859-74.
28. Cohen DJ, Breall JA, Ho KK, et al. Economics of elective coronary revascularization. Comparison of cost and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol 1993;22:1052-9.
29. Palmaz JC. Interfacial relationships and future design consideration. In: Herrmann HC, Hirshfeld JW, eds. Clinical Use of the Palmaz-Schatz Intracoronary Stent. Armonk (NY): Futura, 1993:183-91.
30. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
31. Barragan P, Sainsous J, Silvestri M, et al. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994;32:133-8.
32. Reiber JHC, Van der Zwet PMJ, Koning G, Von Land CD, Van Meurs B, Gerbrands JJ. Accuracy and precision of quantitative digital coronary arteriography; observer-, as well as short-and medium-term variabilities. In: Serruys PW, Foley DP, de Feyter PJ, eds. Quantitative Coronary Angiography in Clinical Practice. Dordrecht: Kluwer, 1994:7-26.
33. Ellis SG, Myler RK, King SB, et al. Causes and correlates of death after unsuccessful coronary angioplasty: implications for use of angioplasty and advanced support strategies in high risk settings. Am J Cardiol 1991;68:1447-51.
34. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: phase 1 findings. N Engl J Med 1985;312:932-6.
35. Wong SC, Schatz RA. Development background and design of the Palmaz-Schatz coronary stents. In Ref. 29:3-19.
36. Palmaz JC. Balloon-expandable intravascular stent. Am J Roentgenol 1988; 150:1263-9.
37. Palmaz JC. Intravascular stenting: from basic research to clinical application. Cardiovasc Intervent Radiol 1992;15:279-84.
38. Merino A, Cohen M, Badimon JJ, Fuster V, Badimon L. Synergistic action of several wall injury and shear forces on thrombus formation in arterial stenosis: definition of a thrombotic shear rate threshold. J Am Coll Cardiol 1994;24:1091-4.
39. Palmaz JC, Windelar S, Garcia F, Tio FO, Sibbitt RR, Reuter SR. Atherosclerotic rabbit aorta: expandable intraluminal grafting. Radiology 1986;160:723-6.
40. Schatz RA, Palmaz JC, Tio FO, García F, García O, Reuter SR. Balloon-expandable intracoronary stents in the adult dog. Circulation 1987;76:450-7.
41. Blengino S, Maiello L, Hall P, Nakamura S, Martini G, Colombo A. Randomized trial of coronary stent implantation without anticoagulation: aspirin vs. ticlopidine. [abstract]. Circulation 1994;90Pt 2:I-124.
42. Fernández-Avilés F, Alonso J, Durán JM, Gimeno F, Muñoz JC, Fuente L. Absence of bleeding and subacute occlusion after Palmaz-Schatz coronary stenting using a new antithrombotic regimen [abstract]. J Am Coll Cardiol 1995;25:96A.
43. Mudra H, Klauss V, Blasini R, Kroetz M, Rieber J, Regar E. Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a combined intravascular ultrasound balloon catheter. Circulation 1994;90:1252-61.
44. Goldberg SL, Comobo A, Nakamura S, et al. Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stent. J Am Coll Cardiol 1994;24:996-1003.
45. Serruys PW, Di Mario C. Who was thrombogenic: the stent or the doctor. Circulation 1995;91:1891-3.
46. Buckley MM, Sorkin EM. Enoxaparin. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders. Drugs 1992;44:465-97.
47. Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs 1990;40:498-530.
48. Teitel JM, Rosenberg RD. Protection of factor Xa from neutralization by the heparin-antithrombin complex. J Clin Invest 1983;71:1383.
49. Padilla A, Cray E, Pepper D, Barrowcliffe T. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4). Br J Haematol 1992;82: 406-13.
50. Hirsh J, Levine M. Low molecular weight heparin. Blood 1993;79:1-17.
51. Ueda Y, Nanto S, Komamura K, Kodama K. Neointimal coverage of stent in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994;23:341-6.